The search found 4059 results.
News
More than five years after the Drug Enforcement Administration (DEA) issued an interim final rule that legalized electronic prescriptions for controlled substances (EPCS), providers and pharmacies are slowly starting to embrace the change.
Press
Lexington, Mass. — (BUSINESS WIRE) — January 11, 2016 — Imprivata® (NYSE: IMPR), the healthcare IT security company, today announced that it expects fourth quarter 2015 revenue to exceed the upper end of its previously announced guidance range of $32-34 million.
News
Alex Perala
February 9, 2015
Imprivata, an IT security company focused on healthcare, has announced the launch of a new electronic medical prescription platform. Imprivata Confirm ID is now available for medical professionals to prescribe controlled substances digitally, allowing for greater efficiency and reliability of documentation and records-keeping.
News
Stacey Collett
February 04, 2015
Each year, the CSO50 awards honor 50 security projects and initiatives that have delivered groundbreaking business value through the innovative application of risk and security concepts and technologies.
News
Stephen Mayhew
February 10, 2015
Imprivata launched Imprivata Confirm ID, a comprehensive product that enables health practitioners to electronically prescribe controlled substances.
Partner
Xenit provides IT infrastructure specialists and market-leading products to assist businesses toward increased efficiency and greater mobility.One way to describe our business is to say that Xenit assists businesses to implement desired changes for a more efficient and secure use of IT. Another way to say what we do is that we deliver IT solutions that provide greater efficiency through improved end user experience and increased availability of mission-critical systems.
Blog
Learn how electronic prescribing of controlled substances (EPCS) can benefit chronic pain patients: it's simple, fast, and secure.
Press
Lexington, Mass.—February 11, 2015—Imprivata® (NYSE: IMPR), the healthcare IT security company, today announced a revised date for its fourth quarter and the full year ended December 31, 2014 conference call. Imprivata will now hold a conference call for investors on Tuesday, February 24 at 5:00 p.m. ET during which management will review highlights from the company's fourth quarter and year end 2014 results, its business outlook and other matters. The Company expects to issue the earnings release after the market closes on Tuesday, February 24, 2015.
News
Erin Bastick
February 11, 2015
Imprivata has launched a new product to enable a major shift from paper to elctronic prescribing of controlled substances.
Press
Symantec Norton Secure Login and Symantec VIP Integrate with Imprivata Confirm ID to Simplify Provider Identity-Proofing and Credentialing Workflows to help meet Regulatory Requirements for EPCS